Corcept Therapeutics (CORT) Posts Wider than Expected Q4 loss of 12c/Share
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $120.89 -1.11%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
XYF, SQZB, RENO, More
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
XYF, SQZB, RENO, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q4 EPS of ($0.12), $0.03 worse than the analyst estimate of ($0.09).
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
- MetLife (MET) PT Raised to $106 at Evercore ISI
- flyExclusive names Brian P. Reid as chief commercial officer
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
